NCT04525066View on ClinicalTrials.gov

Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 13, 2013

Primary Completion Date

August 13, 2018

Study Completion Date

August 13, 2018

Conditions
Head and Neck NeoplasmsHead and Neck Squamous Cell CarcinomaVoice DisordersLaryngeal Cancer
Interventions
DRUG

Hyaluronic acid

Patients in the treatment group received hyaluronic acid injection into the unaffected vocal cord intra-operatively during transoral laser microsurgery for early glottic cancer.

OTHER

No Hyaluronic Acid Injection Injection

Patients in the placebo group did not receive hyaluronic acid injection into the unaffected vocal cord intra-operatively during transoral laser microsurgery for early glottic cancer.

All Listed Sponsors
collaborator

Nova Scotia Health Authority

OTHER

lead

Ayhman Al Afif

OTHER

NCT04525066 - Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma | Biotech Hunter | Biotech Hunter